EyePoint Pharmaceuticals
EYPT
#5277
Rank
โ‚ฌ1.24 B
Marketcap
15,03ย โ‚ฌ
Share price
-1.94%
Change (1 day)
79.42%
Change (1 year)

EyePoint Pharmaceuticals (EYPT) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ0.21 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's total assets are โ‚ฌ0.21 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

EyePoint Pharmaceuticals - Total assets on balance sheet (from 2003 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ0.40 B25.16%
2023-12-31โ‚ฌ0.32 B91.09%
2022-12-31โ‚ฌ0.16 B-27.7%
2021-12-31โ‚ฌ0.23 B211.88%
2020-12-31โ‚ฌ74.56 M14.47%
2019-12-31โ‚ฌ65.13 M
2018-06-30โ‚ฌ61.23 M274.14%
2017-06-30โ‚ฌ16.36 M-42.51%
2016-06-30โ‚ฌ28.47 M-2.06%
2015-06-30โ‚ฌ29.06 M75.57%
2014-06-30โ‚ฌ16.55 M32.6%
2013-06-30โ‚ฌ12.48 M-23.27%
2012-06-30โ‚ฌ16.27 M-49.93%
2011-06-30โ‚ฌ32.49 M-5.5%
2010-06-30โ‚ฌ34.39 M31.07%
2009-06-30โ‚ฌ26.23 M-25.93%
2008-06-30โ‚ฌ35.42 M-53.55%
2007-06-30โ‚ฌ76.26 M-44.75%
2006-06-30โ‚ฌ0.13 B136.18%
2005-06-30โ‚ฌ58.44 M153.41%
2004-06-30โ‚ฌ23.06 M447.28%
2003-06-30โ‚ฌ4.21 M
2001-06-30โ‚ฌ5.55 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
NRC Health
NRC
โ‚ฌ0.11 B-46.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
โ‚ฌ0.23 M-99.89% Bahamas